Vicor price target raised to $175 from $115 at Roth Capital

Roth Capital raised the firm’s price target on Vicor (VICR) to $175 from $115 and keeps a Buy rating on the shares. The company has participated in a conference and provided several key updates that suggest capacity at its first fab is filling materially faster than previously expected, with demand that may necessitate a second fab as early as mid-2027, the analyst tells investors in a research note. The ramp in licensing revenue and improving fab utilization could support an upward revision to Vicor’s gross margin objective from 65% to 70%, the firm added.